Clinical trial using magic mushrooms to treat depression gets go-ahead from FDA

(Natural News) The FDA has just granted U.S. approval to a life sciences startup in London to use the psychedelic ingredient found in magic mushrooms in a trial for treating depression. The startup, Compass Pathways, was launched just two years ago with the backing of Peter Thiel. The trial is a phase IIB study of…

>View original article